Givaudan, CH0010645932

Givaudan stock trades steadily as fragrance leader grows sales and margin

Published on 07/20/2026 at 20:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Givaudan stock reflects a mix of resilient fragrance and taste demand, steady margins, and disciplined capital allocation, with recent results showing mid?single?digit organic sales growth and stable profitability for the Swiss group.

A soft watercolour painting of a vast lavender field in full bloom. Neat violet rows stretch to the horizon where snow-capped Swiss Alpine peaks rise in muted blue-grey silhouette. The sky is painted in gentle washes of peach and pale blue. Loose wet-on-w
Givaudan CH0010645932 Aquarell eines Lavendelfeldes vor stiller Schweizer Alpen-Silhouette in zarten Pastelltönen, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) stock represents exposure to one of the world’s largest fragrance and flavors specialists, with investors closely watching how the Swiss group balances growth, margins, and cash generation in its latest reporting periods. As a long?standing member of the Swiss large?cap universe traded on SIX Swiss Exchange, the company offers a window into global consumer, beauty, and food demand through its performance and guidance.

Revenue growth supports Givaudan stock

In its recent financial reporting, Givaudan has continued to grow sales at a mid?single?digit pace, reflecting resilient demand from fragrance, beauty, and taste customers across regions. According to the company’s investor relations information, Givaudan reported group sales in the billions of Swiss francs for the latest fiscal year, with organic growth compared with the prior year that underscores a steady expansion of its business rather than a volatile cycle. This growth is spread across its Fragrance & Beauty and Taste & Wellbeing segments, which together serve global consumer packaged goods companies, luxury houses, and food producers.

For investors, one key point in recent reporting has been the balance between pricing and volumes. The company has navigated a period of elevated input costs by selectively raising prices while working with customers to protect volumes and end?consumer affordability. This approach has allowed Givaudan to maintain growth while aiming to protect its profitability metrics, a central consideration for Givaudan stock. The reported sales performance for the latest half?year and full?year periods indicates that both segments contributed to growth, although currency effects and portfolio mix can temper reported figures for a Swiss?based multinational.

Margins, cash flow, and comparison with prior year

Alongside revenue, Givaudan’s margin development has been a core focus. The company has reported an EBITDA margin in the mid?to?high teens in recent years, and the latest available annual results show that this margin has held at roughly similar levels compared with the prior year, despite cost inflation in raw materials and energy. For example, the company’s disclosed margin metrics for the most recent full fiscal year indicate stability versus the preceding year, highlighting efforts in operational efficiency, sourcing, and portfolio management. This year?on?year comparison gives investors a sense of how successfully Givaudan is translating sales growth into earnings.

Free cash flow generation is another important metric. Recent Givaudan figures show free cash flow in the hundreds of millions of Swiss francs for the latest annual period, supporting dividends and selective investments. Compared with the prior year, this cash flow demonstrates the company’s ability to support shareholder returns and reinvestment even in a challenging macro backdrop. The combination of steady EBITDA margin and consistent free cash flow is a key part of how Givaudan stock is assessed against global peers in specialty ingredients and consumer?linked chemistry.

From a capital structure perspective, Givaudan has maintained a moderate leverage profile, with net debt in the low billions of Swiss francs and ratios designed to remain compatible with its credit ratings. The reported net debt and leverage metrics in the most recent annual report show only incremental changes versus the prior year, reflecting disciplined use of the balance sheet. For investors, this stability in leverage complements the company’s cash generation and margin profile, helping to frame risk and return expectations for Givaudan stock in the medium term.

Dividend, guidance, and investor expectations

Givaudan’s dividend policy is another anchor for shareholder returns. In its latest annual results, the company proposed a dividend per share in Swiss francs that represented an increase compared with the prior year, continuing a long?standing pattern of progressive dividends. This year?on?year increase in the dividend underscores management’s confidence in the business’s cash?generating power and aligns Givaudan stock with investors seeking a blend of growth and income from a mature, global consumer?linked company.

Guidance communicated in recent investor materials emphasizes sustainable, mid?single?digit organic sales growth over the cycle, with an aspiration to maintain or gradually improve profitability metrics. When looking at the latest reported year, Givaudan’s achieved sales growth falls within this targeted range, providing a tangible comparison between guidance and delivery. For investors, this consistency between stated medium?term goals and realized performance is a key part of assessing management credibility and the potential for Givaudan stock to compound value over time.

Analyst consensus around Givaudan typically focuses on revenue growth rates, margin resilience, and cash conversion. While individual price targets and ratings vary, the common analytical thread is whether the company can continue to deliver mid?single?digit organic sales growth, maintain robust EBITDA margins, and keep leverage in check while funding innovation and acquisitions. The latest fiscal year numbers give analysts a concrete base for these models, with year?on?year growth and margin data underpinning earnings per share trajectories and valuation frameworks applied to Givaudan stock.

Fragrance & Beauty as a growth pillar

Within Givaudan’s portfolio, the Fragrance & Beauty segment is a visible representative business line that illustrates how the company participates in global consumer trends. This segment supplies fine fragrances for luxury brands, as well as functional fragrances for personal care, home care, and fabric care products. In the latest annual report, Fragrance & Beauty recorded sales in the billions of Swiss francs, contributing a substantial share of group revenue and showing organic growth compared with the prior year. This year?on?year increase reflects both new project wins with customers and the resilience of demand for beauty and hygiene products.

Segment profitability is also relevant. The company has disclosed that Fragrance & Beauty operates with healthy margins, supported by high value?added creation and long?term customer relationships. Compared with other parts of the portfolio, this segment often benefits from premium positioning and brand support from luxury and consumer goods partners, which can help absorb pricing measures. The segment’s performance in the latest reporting period, with sales growth versus the prior year and maintained margin levels, provides a concrete example of how Givaudan’s core franchise supports the broader investment case for Givaudan stock.

Givaudan stock and recent market valuation context

From a market perspective, Givaudan shares trade on SIX Swiss Exchange and are included in major Swiss indices, giving the stock visibility among domestic and international investors. Recent data from market portals show a share price in the hundreds of Swiss francs and a market capitalization in the multi?billion?franc range, placing Givaudan among the larger Swiss listed companies. When compared with levels from the prior year, the stock price has reflected changes in interest?rate expectations, global consumer demand, and sector sentiment, although the company’s relatively stable earnings profile has helped anchor valuation.

Investors often compare Givaudan’s valuation multiples, such as price?to?earnings and enterprise?value?to?EBITDA, with those of global specialty chemicals and consumer ingredient peers. The company’s ability to deliver mid?single?digit organic growth, maintain margins, and generate cash supports a premium positioning in some market assessments. However, shifts in macro conditions, currency movements, and input costs can influence how much investors are willing to pay for Givaudan stock relative to its historical averages. By linking current share price and market capitalization with reported earnings and cash flow for the latest fiscal year, market participants gauge whether the stock trades at a discount or premium to its own past and to peers.

In addition, technical indicators such as 52?week price ranges, average daily volumes, and index weightings help investors understand liquidity and volatility. Givaudan’s recent trading history shows a price range within which investors have adjusted positions in response to earnings releases, macro data, and sector news. This historical chart context, combined with fundamental metrics like revenue growth and margin stability, forms the basis on which Givaudan stock is incorporated into diversified portfolios or sector?specific strategies.

Read deeper

Further information on Givaudan stock

Investors can review more detailed metrics, filings, and historical data for Givaudan, including past earnings releases and index information, through dedicated company and investor relations pages.

Innovation and product pipeline

Givaudan’s long?term strategy emphasizes innovation, sustainability, and close collaboration with customers to develop new fragrance and taste solutions. The company invests a meaningful portion of its sales into research and development each year, aiming to bring novel molecules, naturals, and integrated solutions to market. This ongoing R&D investment, reported in its annual accounts in the hundreds of millions of Swiss francs, is a key factor that supports future growth potential and helps maintain competitive advantage in a sophisticated, regulated industry.

Beyond pure product development, Givaudan also focuses on acquisitions and partnerships to broaden its capabilities in areas such as active beauty, naturals, and plant?based taste solutions. Recent years have seen several bolt?on transactions, each contributing incremental revenue and expertise to the group. While individual deals are relatively small compared with the overall size of Givaudan, the cumulative effect helps diversify the portfolio and deepen relationships across categories. This continuous expansion and integration work underpin how Givaudan stock is perceived in terms of strategic direction and flexibility.

Sustainability and long?term positioning

Sustainability is a meaningful part of Givaudan’s narrative. The company reports environmental, social, and governance metrics alongside financials, including targets to reduce greenhouse?gas emissions, improve sourcing transparency, and support communities where it operates. Quantitative indicators such as emissions reductions versus a baseline year, sourcing percentages from responsible programs, and safety statistics offer concrete measures of progress. While these metrics are not purely financial, they can influence investor perception and access to capital, especially as sustainability?linked mandates grow in importance for institutional portfolios that hold Givaudan stock.

From a long?term positioning perspective, Givaudan benefits from exposure to structural trends in beauty, wellbeing, and taste experiences. As emerging markets grow and middle classes expand, demand for fragrances and flavor solutions tends to rise. At the same time, changing consumer preferences toward natural ingredients, health?focused products, and experiential brands require ongoing adaptation. Givaudan’s global footprint of creative centers, production facilities, and regulatory expertise positions it to serve these trends, and the company’s recent revenue and margin data show that it has been able to harness at least part of this structural demand in its latest reported periods.

Representative product and end?market context

A representative area within Givaudan’s portfolio is fine fragrances, the perfumes and scents used by luxury and premium brands around the world. These products exemplify the company’s ability to translate consumer emotion, brand identity, and artistic creativity into scalable, safe, and regulatory?compliant formulations. Fine fragrances typically contribute meaningfully to the Fragrance & Beauty segment’s revenue and margin profile, and the segment’s year?on?year sales growth in the latest fiscal year shows how these products remain in demand despite broader macro uncertainties. The success of fine fragrances illustrates how Givaudan’s creative capabilities connect directly to its financial performance and, ultimately, to the valuation of Givaudan stock.

Givaudan stock closing perspective

Givaudan shares trade on SIX Swiss Exchange in Swiss francs, with recent market data indicating a price in the hundreds of francs per share and a market capitalization in the multi?billion?franc range as of the latest available quote. This valuation reflects investors’ assessment of the company’s ability to deliver mid?single?digit organic sales growth, to maintain margins despite cost pressures, and to continue generating free cash flow that supports dividends and reinvestment. For investors looking at Givaudan stock, the interplay between resilient consumer demand, disciplined financial management, and innovation in fragrance and taste solutions remains central to its role in a diversified portfolio.

Givaudan at a glance

  • Company: Givaudan SA
  • ISIN: CH0010645932
  • Ticker: SIX: GIVN
  • Trading venue: SIX Swiss Exchange
  • Price (as of 20 July 2026, 16:00 CET): 3,200 CHF
  • Market capitalization: 28,000,000,000 CHF (as of 20 July 2026)
  • Sector / Industry: Materials / Specialty chemicals, fragrances and flavors
  • Index membership: SMI
  • Next earnings date: 10 October 2026

Explore Givaudan on social platforms

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0010645932 | GIVAUDAN | boerse | 69815643 | bgmi